Research output per year
Research output per year
Personal profile
specialisation
Thoracic Oncology
Research interests
Idris Bahce is a Thoracic Oncologist and Associate Professor of the Multidisciplinary Thoracic Oncology Research Group at Amsterdam UMC.
Background
Idris Bahce finished his medical degree (CUM LAUDE) at the University of Leuven in 2003. He finished his specialization as a pulmonologist in 2009 in Arnhem. During his PhD, at the Amsterdam UMC location VUmc, he investigated the potential of PET using radiolabeled targeting agents, i.e. TKI-PET using [11C]C-erlotinib and immune-PET using [89Zr]Zr-bevacizumab, directed against non-small cell lung cancer (NSCLC), to characterize tumors and determine their sensitivity to the given agents. For his research he received the Woldringprijs in 2018, the Dutch award for the best PhD research in the field of nuclear medicine issued by NVNG.
Research Interests
- Resistance mechanisms of immunotherapy in NSCLC
- Multimodality combination immunotherapies
- PET imaging using radiolabeled drugs against lung cancer
ACTIVITIES
- Member Theme leaders ‘Cancer Immunology’, Cancer Center Amsterdam (CCA) and Amsterdam institute for Infection and Immunity (AII)
- Member Guidelines Commission (Richtlijnencommissie) NVALT, Dutch Guidelines on Non-small Cell Lung Cancer
- Member Guidelines Commission (Richtlijnencommissie) NVALT, Dutch Guidelines on Lung Cancer Surgery Guidelines
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
89Zr-immuno-PET using the anti-LAG-3 tracer [89Zr]Zr-BI 754111: demonstrating target specific binding in NSCLC and HNSCC
Miedema, I. H. C., Huisman, M. C., Zwezerijnen, G. J. C., Grempler, R., Pitarch, A. P., Thiele, A., Hesse, R., Elgadi, M., Peltzer, A., Vugts, D. J., van Dongen, G. A. M. S., de Gruijl, T. D., Menke-van der Houven van Oordt, C. W. & Bahce, I., Jun 2023, In: European journal of nuclear medicine and molecular imaging. 50, 7, p. 2068-2080 13 p.Research output: Contribution to journal › Article › Academic › peer-review
Open Access2 Citations (Scopus) -
Association of Machine Learning-Based Assessment of Tumor-Infiltrating Lymphocytes on Standard Histologic Images With Outcomes of Immunotherapy in Patients With NSCLC
Rakaee, M., Adib, E., Ricciuti, B., Sholl, L. M., Shi, W., Alessi, J. V., Cortellini, A., Fulgenzi, C. A. M., Viola, P., Pinato, D. J., Hashemi, S., Bahce, I., Houda, I., Ulas, E. B., Radonic, T., V?yrynen, J. P., Richardsen, E., Jamaly, S., Andersen, S., Donnem, T., & 2 others, 19 Jan 2023, In: JAMA Oncology. 9, 1, p. 51-60 10 p.Research output: Contribution to journal › Article › Academic › peer-review
17 Citations (Scopus) -
Feasibility of salvage resection following locoregional failure after chemoradiotherapy and consolidation durvalumab for unresectable stage III non-small cell lung cancer
Dickhoff, C., Unal, S., Heineman, D. J., Winkelman, J. A., Braun, J., Bahce, I., van Dorp, M., Senan, S. & Dahele, M., 1 Aug 2023, In: Lung Cancer. 182, 107294.Research output: Contribution to journal › Article › Academic › peer-review
Open Access -
Focal 18F-FDG uptake predicts progression of pre-invasive squamous bronchial lesions to invasive cancers
Smesseim, I., van Boerdonk, R. A., Dickhoff, C., Heineman, D. J., Dahele, M. R., Radonic, T., Bahce, I., Rauh, S. P., Comans, E. F. I. & Daniels, H., Mar 2023, In: Thoracic Cancer. 14, 9, p. 840-847 8 p.Research output: Contribution to journal › Article › Academic › peer-review
Open Access -
Influence of germline variations in drug transporters ABCB1 and ABCG2 on intracerebral osimertinib efficacy in patients with non-small cell lung cancer
Veerman, G. D. M., Boosman, R. J., Jebbink, M., Oomen-de Hoop, E., van der Wekken, A. J., Bahce, I., Hendriks, L. E. L., Croes, S., Steendam, C. M. J., de Jonge, E., Koolen, S. L. W., Steeghs, N., van Schaik, R. H. N., Smit, E. F., Dingemans, A-M. C., Huitema, A. D. R. & Mathijssen, R. H. J., 1 May 2023, In: EClinicalMedicine. 59, 101955.Research output: Contribution to journal › Article › Academic › peer-review
Open Access